Frontiers in adjuvant therapy in stage II-III melanoma

被引：0
|
作者：
Eggermont, AMM [1 ]
机构：
[1] Univ Rotterdam Hosp, Dr Daniel Den Hoed Canc Ctr, Dept Surg Oncol, NL-3075 EA Rotterdam, Netherlands
来源：
TUMORI JOURNAL | 2001年 / 87卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S60 / S63
页数：4
相关论文
共 50 条
  • [21] Adjuvant therapy for stage II and III colorectal cancer
    de Gramont, Aimery
    Tournigand, Christophe
    Andre, Thierry
    Larsen, Annette K.
    Louvet, Christophe
    SEMINARS IN ONCOLOGY, 2007, 34 (02) : S37 - S40
  • [22] Adjuvant therapy of stage II and III colon cancer
    de Gramont, A
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S11 - S14
  • [23] Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: A feasibility study
    Lupattelli, Marco
    Maranzano, Ernesto
    Bellavita, Rita
    Natalini, Giovanni
    Corgna, Enrichetta
    Rossetti, Riccardo
    Trippa, Fabio
    Mascioni, Francesca
    Sidoni, Angelo
    Anselmo, Paola
    Buzzi, Franco
    Brugia, Mauro
    Latini, Paolo
    TUMORI JOURNAL, 2005, 91 (06): : 498 - 504
  • [24] Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: A phase II study.
    Draghini, L.
    Lupattelli, M.
    Bellavita, R.
    Maranzano, E.
    Beneventi, S.
    D'Ambrosio, M. S.
    Trippa, F.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S240 - S241
  • [25] Adjuvant therapy for stage II melanoma: the need for further studies
    Lee, Rebecca
    Mandala, Mario
    V. Long, Georgina
    Eggermont, Alexander M. M.
    van Akkooi, Alexander C. J.
    Sandhu, Shahneen
    Garbe, Claus
    Lorigan, Paul
    EUROPEAN JOURNAL OF CANCER, 2023, 189
  • [26] Where Are We With Adjuvant Therapy of Stage III and IV Melanoma in 2009?
    Fecher, Leslie A.
    Flaherty, Keith T.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (03): : 295 - 304
  • [27] Factors associated with the use of adjuvant radiation therapy in stage III melanoma
    King, Amber L. O.
    Lee, Victor
    Yu, Beverly
    Mirza, Fatima N.
    Zogg, Cheryl K.
    Yang, Daniel X.
    Tran, Thuy
    Leventhal, Jonathan
    An, Yi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Adjuvant therapy utilization among stage III melanoma patients.
    Cowey, C. Lance
    Ghate, Sameer R.
    Rhodes, Whitney C.
    Wilson, Thomas
    Ndife, Briana
    Espirito, Janet L.
    Borker, Rohit
    Frytak, Jennifer R.
    Nakasato, Antonio Reis
    Robert, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
    Barker, Christopher A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 11 - 12
  • [30] Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer
    Matthews, Benjamin J.
    Qureshi, Muhammad Mustafa
    Fiascone, Stephen J.
    Nitschmann, Caroline C.
    Oladeru, Oluwadamilola T.
    Truong, Minh-Tam
    Hirsch, Ariel E.
    Mak, Kimberley S.
    Dyer, M. A.
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : 27 - 33
12345